| Drug | Class | Adult | Paediatric | Notes |
|---|---|---|---|---|
| Labetalol (oral or IV)[1] | Combined alpha-1 / non-selective beta-blocker | Oral 100–200 mg PO BD-TDS, max 1200 mg/day. IV severe HTN: 20 mg IV bolus, repeat 40, 80 mg every 10 min (max 220 mg) | — | First-line in pregnancy; avoid in asthma, bradycardia, heart block; safe in breastfeeding |
| Nifedipine[1] | Calcium channel blocker (DHP) | Immediate-release 10 mg PO for severe acute HTN (repeat at 20 min if needed); ER 30–60 mg PO daily for maintenance | — | First-line maintenance; useful in asthma; combine with labetalol for resistant; do not use sublingual immediate-release |
| Hydralazine (severe acute HTN)[1] | Direct arterial vasodilator | 5 mg IV bolus, repeat 5–10 mg every 20 min (max 30 mg) or infusion 0.5–10 mg/h | — | Severe pregnancy hypertension when labetalol contraindicated or not available; reflex tachycardia, headache |
| Magnesium sulfate (eclampsia prevention and treatment)[1] | Anticonvulsant / NMDA modulator | Loading 4–6 g IV over 15–20 min, maintenance 1–2 g/h IV for 24 h after delivery or last seizure | — | Severe pre-eclampsia and eclampsia; monitor patellar reflex, respiratory rate, urine output; calcium gluconate antidote for toxicity |
Diagnosis and management of gestational hypertension, pre-eclampsia, eclampsia, and chronic hypertension in pregnancy and postpartum.